Alexandre Surget
Overview
Explore the profile of Alexandre Surget including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
3033
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zapata Cardona J, Duque Arias S, David Jaramillo E, Surget A, Ibarguen-Vargas Y, Rodriguez B
Sci Rep
. 2024 Aug;
14(1):18660.
PMID: 39134584
Intensification of swine production can predispose pigs to chronic stress, with adverse effects on the neuroendocrine and immune systems that can lead to health problems, poor welfare, and reduced production...
2.
Eyraud N, Bloch S, Brizard B, Pena L, Tharsis A, Surget A, et al.
Brain Sci
. 2024 Apr;
14(4).
PMID: 38671963
Posttraumatic stress disorder (PTSD) is a widespread fear-related psychiatric affection associated with fear extinction impairments and important avoidance behaviors. Trauma-related exposure therapy is the current first-hand treatment for PTSD, yet...
3.
Gallet Q, Bouteloup V, Locatelli M, Habert M, Chupin M, Campion J, et al.
Am J Geriatr Psychiatry
. 2023 Nov;
32(6):665-677.
PMID: 37973486
Objective: We sought to examine the association between chronic Benzodiazepine (BZD) use and brain metabolism obtained from 2-deoxy-2-fluoro-D-glucose (FDG) positron emission tomography (PET) in the MEMENTO clinical cohort of nondemented...
4.
Noureddine R, Surget A, Iazourene T, Audebrand M, Eliwa H, Brizard B, et al.
Ultrasonics
. 2022 Nov;
128:106888.
PMID: 36402114
Background: Ultrasound neurostimulation (USNS) is a non-invasive neuromodulation technique that might hold promise for treating neuropsychiatric disorders with regards to its noninvasiveness, penetration depth, and high resolution. Objective: We sought...
5.
Accrombessi G, Galineau L, Tauber C, Serriere S, Moyer E, Brizard B, et al.
Transl Psychiatry
. 2022 Sep;
12(1):356.
PMID: 36050307
The different depressive disorders that exist can take root at adolescence. For instance, some functional and structural changes in several brain regions have been observed from adolescence in subjects that...
6.
Ibarguen-Vargas Y, Leman S, Palme R, Belzung C, Surget A
Pharmaceutics
. 2021 Dec;
13(12).
PMID: 34959395
Despite promising initial reports, corticotropin-releasing factor receptor type-1 (CRF-R1) antagonists have mostly failed to display efficacy in clinical trials for anxiety or depression. Rather than broad-spectrum antidepressant/anxiolytic-like drugs, they may...
7.
Gallet Q, Bouteloup V, Locatelli M, Habert M, Chupin M, Delrieu J, et al.
Neuropsychopharmacology
. 2021 Dec;
47(5):1114-1120.
PMID: 34893757
Recent evidence suggests an association between benzodiazepines (BZDs) use and lower brain amyloid load, a hallmark of AD pathophysiology. Other AD-related markers include hippocampal atrophy, but the effect of BZDs...
8.
Planchez B, Lagunas N, Le Guisquet A, Legrand M, Surget A, Hen R, et al.
Cells
. 2021 Apr;
10(5).
PMID: 33919292
Many studies evaluated the functional role of adult hippocampal neurogenesis (AHN) and its key role in cognitive functions and mood regulation. The effects of promoting AHN on the recovery of...
9.
Troubat R, Leman S, Pinchaud K, Surget A, Barone P, Roger S, et al.
Brain Behav Immun
. 2021 Feb;
94:159-174.
PMID: 33609652
Background: Several lines of evidence suggest that neuroinflammation might be a key neurobiological mechanism of depression. In particular, the P2X7 receptor (P2X7R), an ATP-gated ion channel involved in activation of...
10.
Eliwa H, Brizard B, Le Guisquet A, Hen R, Belzung C, Surget A
Psychoneuroendocrinology
. 2020 Dec;
124:105097.
PMID: 33302237
Major depressive disorder is a common debilitating mental health problem that represents one of the leading causes of disability. Up to date, the therapeutic targets and approaches are still limited....